BridgeBio has significantly advanced its course of a innovative therapy for amyloid heart disease, utilizing Attruby. Initial patient data indicates promising outcomes for individuals diagnosed by the serious illness. https://attr-cm109476.amoblog.com/company-improves-amyloidosis-therapy-through-the-therapy-64268709